EP1137938A4 - Methodes de depistage d'agonistes et d'antagonistes du recepteur de hdpxu17 - Google Patents

Methodes de depistage d'agonistes et d'antagonistes du recepteur de hdpxu17

Info

Publication number
EP1137938A4
EP1137938A4 EP99964135A EP99964135A EP1137938A4 EP 1137938 A4 EP1137938 A4 EP 1137938A4 EP 99964135 A EP99964135 A EP 99964135A EP 99964135 A EP99964135 A EP 99964135A EP 1137938 A4 EP1137938 A4 EP 1137938A4
Authority
EP
European Patent Office
Prior art keywords
hdpxu17
agonists
antagonists
receptor
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99964135A
Other languages
German (de)
English (en)
Other versions
EP1137938A1 (fr
Inventor
Derk J Bergsma
Wendy S Halsey
Ganesh Sathe
Da-Yuan Wang
Jeffrey S Culp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1137938A1 publication Critical patent/EP1137938A1/fr
Publication of EP1137938A4 publication Critical patent/EP1137938A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
EP99964135A 1998-12-08 1999-12-07 Methodes de depistage d'agonistes et d'antagonistes du recepteur de hdpxu17 Withdrawn EP1137938A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29749398A 1998-12-08 1998-12-08
US297493 1998-12-08
PCT/US1999/028941 WO2000034783A1 (fr) 1998-12-08 1999-12-07 Methodes de depistage d'agonistes et d'antagonistes du recepteur de hdpxu17

Publications (2)

Publication Number Publication Date
EP1137938A1 EP1137938A1 (fr) 2001-10-04
EP1137938A4 true EP1137938A4 (fr) 2003-03-19

Family

ID=23146550

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99964135A Withdrawn EP1137938A4 (fr) 1998-12-08 1999-12-07 Methodes de depistage d'agonistes et d'antagonistes du recepteur de hdpxu17

Country Status (2)

Country Link
EP (1) EP1137938A4 (fr)
WO (1) WO2000034783A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523523A (en) * 2000-07-07 2003-10-31 Univ North Carolina Method for screening candidate substances for ability to modulate P2Y receptor-mediated biological activity
EP2360275B1 (fr) 2000-11-15 2018-03-28 Minerva Biotechnologies Corporation Identifiants d'oligonucléotides
EP1354196B1 (fr) 2000-11-27 2010-09-15 Minerva Biotechnologies Corporation Marqueurs tumoraux de diagnostic, analyse de medicaments pour l'inhibition de la tumorigenese, et compositions et procedes pour le traitement du cancer
EP2116248A1 (fr) 2001-09-05 2009-11-11 Minerva Biotechnologies Corporation Compositions et procédés pour le traitement du cancer
CA2537263C (fr) 2002-11-27 2017-05-30 Minerva Biotechnologies Corporation Techniques et compositions pour le diagnostic et le traitement du cancer (muc1)
JP2012505636A (ja) 2008-10-09 2012-03-08 ミネルバ バイオテクノロジーズ コーポレーション 細胞において多能性を誘導する方法
NZ601242A (en) * 2009-12-29 2013-06-28 Suven Life Sciences Ltd Functional assay for g protein-coupled receptors
EP2686418A4 (fr) 2011-03-17 2015-04-22 Minerva Biotechnologies Corp Procédé d'obtention de cellules souches pluripotentes
EP3256494A4 (fr) 2015-02-10 2018-12-05 Minerva Biotechnologies Corporation Anticorps anti-muc1* humanisés

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002675A1 (fr) * 1997-07-09 1999-01-21 Euroscreen S.A. Recepteur couple a la proteine g presentant une affinite selective pour l'atp et molecule d'acide nucleique codant ce recepteur

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981223A (en) * 1998-01-20 1999-11-09 Smithkline Beecham Corporation HDPXU17 encodes a novel 7-transmembrane receptor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002675A1 (fr) * 1997-07-09 1999-01-21 Euroscreen S.A. Recepteur couple a la proteine g presentant une affinite selective pour l'atp et molecule d'acide nucleique codant ce recepteur

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0034783A1 *

Also Published As

Publication number Publication date
EP1137938A1 (fr) 2001-10-04
WO2000034783A1 (fr) 2000-06-15

Similar Documents

Publication Publication Date Title
EP1100506A4 (fr) Antagonistes des recepteurs de l'integrine
EP1105389A4 (fr) Antagonistes de recepteurs d'integrine
AU4552099A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT2 receptors
EP1047425A4 (fr) Antagonistes du recepteur de l'integrine
GB9927227D0 (en) CCR-3 receptor antagonists III
PT1131291E (pt) Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
EP1007051A4 (fr) Antagonistes du recepteur de l'integrine
EP0880511A4 (fr) Antagonistes du recepteur integrine
PL346247A1 (en) Muscarinic agonists and antagonists
PL341114A1 (en) Antagonists of thrombosin receptors
AUPP380498A0 (en) Egf receptor agonists and antagonists
HUP0203371A3 (en) Adenosine receptor antagonists and methods of making and using the same
EP1027337A4 (fr) Antagonistes des recepteurs d'integrines
EP1137938A4 (fr) Methodes de depistage d'agonistes et d'antagonistes du recepteur de hdpxu17
HU9702039D0 (en) Estrogen agonist/antagonists treatment of atheroscerosis
AU6263996A (en) Method for screening for receptor agonists and antagonists
AU5861900A (en) Receptor agonists and antagonists
GB9820014D0 (en) Receptor antagonists and uses thereof
AU4980999A (en) A3 adenosine receptor antagonists
PL346157A1 (en) Vitronectin receptor antagonists
HU9902674D0 (en) Estrogen agonists/antagonists
AU4551499A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-HT3 receptors
EP0928194A4 (fr) Compositions et procedes utilises pour administrer des antagonistes du recepteur de l'integrine
GB9811283D0 (en) Vironectin receptor antagonists
AUPP058597A0 (en) Receptor agonists and antagonists

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010709

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CULP, JEFFREY, S.

Inventor name: WANG, DA-YUAN

Inventor name: SATHE, GANESH

Inventor name: HALSEY, WENDY, S.

Inventor name: BERGSMA, DERK, J.

A4 Supplementary search report drawn up and despatched

Effective date: 20030203

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/50 B

Ipc: 7G 01N 33/566 B

Ipc: 7G 01N 33/53 A

REG Reference to a national code

Ref country code: DE

Ref legal event code: 8566

17Q First examination report despatched

Effective date: 20030714

RBV Designated contracting states (corrected)

Designated state(s): GB

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040127